WI Harper Group-backed EdiGene Raises ~USD 67 Million in Series B Financing to Advance Gene Editing Based Programs into Clinical Stage

WI Harper Group | October 14, 2020 |  Source: Businesswire WI Harper Group backed EdiGene, Inc., which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases, announced the successful completion of a RMB 450 million (approximately USD 67 million) Series B financing. 3H Health Investment led…